Lincoln Pharmaceuticals Limited (LINCOLN.NS)
INR 552.6
(3.05%)
INR 552.6
(3.05%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 933.04 Million INR | 27.99% |
| 2022 | 728.99 Million INR | 5.11% |
| 2021 | 693.55 Million INR | 11.41% |
| 2020 | 622.5 Million INR | 21.02% |
| 2019 | 514.39 Million INR | 5.6% |
| 2018 | 487.1 Million INR | 40.69% |
| 2017 | 346.22 Million INR | 27.93% |
| 2016 | 270.64 Million INR | 14.28% |
| 2015 | 236.82 Million INR | 57.75% |
| 2014 | 150.12 Million INR | 40.9% |
| 2013 | 106.54 Million INR | 10.27% |
| 2012 | 96.62 Million INR | 88.76% |
| 2011 | 51.18 Million INR | 22.86% |
| 2010 | 41.66 Million INR | -31.75% |
| 2009 | 61.04 Million INR | -13.64% |
| 2008 | 70.68 Million INR | 51.59% |
| 2007 | 46.62 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 236.71 Million INR | 27.29% |
| 2023 Q4 | 185.97 Million INR | -33.68% |
| 2023 FY | 933.04 Million INR | 27.99% |
| 2023 Q1 | 190.13 Million INR | 51.36% |
| 2023 Q2 | 276.54 Million INR | 45.45% |
| 2023 Q3 | 280.4 Million INR | 1.4% |
| 2022 Q2 | 237.12 Million INR | 57.96% |
| 2022 Q3 | 216.12 Million INR | -8.86% |
| 2022 Q4 | 125.61 Million INR | -41.88% |
| 2022 Q1 | 150.11 Million INR | 36.17% |
| 2022 FY | 728.99 Million INR | 5.11% |
| 2021 Q4 | 110.23 Million INR | -37.4% |
| 2021 FY | 693.55 Million INR | 11.41% |
| 2021 Q1 | 176.98 Million INR | 40.77% |
| 2021 Q2 | 230.24 Million INR | 30.1% |
| 2021 Q3 | 176.08 Million INR | -23.52% |
| 2020 Q3 | 134.81 Million INR | -35.53% |
| 2020 Q2 | 209.11 Million INR | 37.06% |
| 2020 Q1 | 152.57 Million INR | 70.58% |
| 2020 Q4 | 125.72 Million INR | -6.74% |
| 2020 FY | 622.5 Million INR | 21.02% |
| 2019 Q3 | 109.1 Million INR | -42.31% |
| 2019 Q4 | 89.44 Million INR | -18.02% |
| 2019 FY | 514.39 Million INR | 5.6% |
| 2019 Q1 | 126.69 Million INR | 49.13% |
| 2019 Q2 | 189.14 Million INR | 49.29% |
| 2018 Q1 | 160.67 Million INR | 135.2% |
| 2018 Q4 | 84.95 Million INR | -7.12% |
| 2018 Q2 | 149.99 Million INR | -6.65% |
| 2018 Q3 | 91.46 Million INR | -39.02% |
| 2018 FY | 487.1 Million INR | 40.69% |
| 2017 Q3 | 115.77 Million INR | 2.42% |
| 2017 FY | 346.22 Million INR | 27.93% |
| 2017 Q4 | 68.31 Million INR | -40.99% |
| 2017 Q2 | 113.03 Million INR | 130.2% |
| 2017 Q1 | 49.1 Million INR | 390.99% |
| 2016 FY | 270.64 Million INR | 14.28% |
| 2016 Q3 | 64.71 Million INR | -25.29% |
| 2016 Q2 | 86.62 Million INR | -20.76% |
| 2016 Q1 | 109.31 Million INR | 172.08% |
| 2016 Q4 | 10 Million INR | -84.55% |
| 2015 Q3 | 64.43 Million INR | -3.58% |
| 2015 Q1 | 65.38 Million INR | 197.05% |
| 2015 FY | 236.82 Million INR | 57.75% |
| 2015 Q2 | 66.82 Million INR | 2.2% |
| 2015 Q4 | 40.17 Million INR | -37.64% |
| 2014 Q2 | 69.92 Million INR | 116.6% |
| 2014 Q4 | 22.01 Million INR | -15.0% |
| 2014 Q3 | 25.89 Million INR | -62.97% |
| 2014 Q1 | 32.28 Million INR | 363.28% |
| 2014 FY | 150.12 Million INR | 40.9% |
| 2013 Q3 | 33 Million INR | -3.36% |
| 2013 Q1 | 32.41 Million INR | -20.74% |
| 2013 Q2 | 34.15 Million INR | 5.38% |
| 2013 Q4 | 6.96 Million INR | -78.89% |
| 2013 FY | 106.54 Million INR | 10.27% |
| 2012 Q4 | 40.89 Million INR | 173.59% |
| 2012 Q3 | 14.94 Million INR | -54.31% |
| 2012 Q2 | 32.71 Million INR | 305.15% |
| 2012 Q1 | 8.07 Million INR | 5.53% |
| 2012 FY | 96.62 Million INR | 88.76% |
| 2011 Q3 | 5.19 Million INR | 0.0% |
| 2011 FY | 51.18 Million INR | 22.86% |
| 2011 Q4 | 7.65 Million INR | 47.3% |
| 2010 FY | 41.66 Million INR | -31.75% |
| 2009 FY | 61.04 Million INR | -13.64% |
| 2008 FY | 70.68 Million INR | 51.59% |
| 2008 Q4 | -3.85 Million INR | 0.0% |
| 2007 FY | 46.62 Million INR | 0.0% |
| 2007 Q4 | 876 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 84.849% |
| Hester Biosciences Limited | 188.89 Million INR | -393.964% |
| Aarti Drugs Limited | 1.71 Billion INR | 45.569% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 56.983% |
| Albert David Limited | 754.2 Million INR | -23.714% |
| Alembic Limited | 2.68 Billion INR | 65.265% |
| Alkem Laboratories Limited | 17.95 Billion INR | 94.804% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -1169.817% |
| Bajaj HealthCare Limited | -837.93 Million INR | 211.352% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -13056.359% |
| Brooks Laboratories Limited | -195.91 Million INR | 576.242% |
| Eris Lifesciences Limited | 3.91 Billion INR | 76.197% |
| FDC Limited | 3.05 Billion INR | 69.431% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 80.185% |
| Gufic Biosciences Limited | 861.35 Million INR | -8.323% |
| Hikal Limited | 696 Million INR | -34.059% |
| Ind-Swift Limited | 142.31 Million INR | -555.632% |
| Innova Captab Limited | 943.45 Million INR | 1.102% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 30.592% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -315.371% |
| Jubilant Pharmova Limited | 771 Million INR | -21.018% |
| Lupin Limited | 19.14 Billion INR | 95.126% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 1128.527% |
| Medico Remedies Limited | 82.9 Million INR | -1025.389% |
| Morepen Laboratories Limited | 961.59 Million INR | 2.969% |
| Nectar Lifesciences Limited | 49.95 Million INR | -1767.966% |
| Orchid Pharma Limited | 921.66 Million INR | -1.235% |
| Procter & Gamble Health Limited | 2 Billion INR | 53.575% |
| RPG Life Sciences Limited | 876.6 Million INR | -6.44% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -539.013% |
| Sigachi Industries Limited | 571.8 Million INR | -63.177% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 116.445% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 68.927% |
| Themis Medicare Limited | 435.23 Million INR | -114.377% |
| Unichem Laboratories Limited | -704.74 Million INR | 232.396% |
| Vaishali Pharma Limited | 7.18 Million INR | -12878.843% |
| Wanbury Limited | 559.56 Million INR | -66.746% |
| Windlas Biotech Limited | 581.87 Million INR | -60.354% |
| ZIM Laboratories Limited | 172.46 Million INR | -441.011% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 77.835% |
| Ipca Laboratories Limited | 5.47 Billion INR | 82.953% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.026% |
| Venus Remedies Limited | 284.9 Million INR | -227.491% |
| Sakar Healthcare Limited | 116.7 Million INR | -699.466% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 97.059% |
| Divi's Laboratories Limited | 16 Billion INR | 94.168% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 42.23% |
| Mankind Pharma Limited | 19.12 Billion INR | 95.122% |
| Sequent Scientific Limited | -358.69 Million INR | 360.127% |
| Laurus Labs Limited | 1.6 Billion INR | 41.884% |
| Neuland Laboratories Limited | 3 Billion INR | 68.907% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 83.116% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 106.213% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 97.582% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -107.471% |
| Wockhardt Limited | -4.63 Billion INR | 120.152% |
| Bal Pharma Limited | 73.92 Million INR | -1162.207% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 98.324% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -23.658% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -543.438% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 79.587% |
| Shilpa Medicare Limited | 318.74 Million INR | -192.729% |
| Valiant Laboratories Limited | 3.19 Million INR | -29094.274% |
| Ajanta Pharma Limited | 8.16 Billion INR | 88.568% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -1892.133% |
| Granules India Limited | 4.05 Billion INR | 76.979% |
| Medicamen Biotech Limited | 109.31 Million INR | -753.581% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -268.587% |
| Piramal Enterprises Limited | -16.83 Billion INR | 105.542% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 94.367% |
| NATCO Pharma Limited | 13.88 Billion INR | 93.279% |
| Suven Life Sciences Limited | -1.05 Billion INR | 188.797% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 572.947% |
| Strides Pharma Science Limited | -706.14 Million INR | 232.134% |
| Indoco Remedies Limited | 984.6 Million INR | 5.236% |
| Alpa Laboratories Limited | 167.76 Million INR | -456.164% |
| Lasa Supergenerics Limited | -217.3 Million INR | 529.371% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 124.096% |